Abstract
Two years ago I described a method for obtaining soluble preparations of pertussis mouse protective antigen (immunogen) by lysing the bacterial cells with sodium deoxycholate1. I now wish to report the partial purification of these extracts, using the organic bases benzathene and proflavine as precipitating agents. In a typical experiment with the former, deoxycholate lysate of pertussis derived from a cell concentration of 320 opacity units (OU) per ml. was treated dropwise at pH. 7.4–7.5 at room temperature with a 14 per cent (w/v) solution of benzathene (dibenzylethylene diamine acetate). The mixture was shaken continuously and its optical density monitored until maximum density, indicative of maximum precipitation, was reached, after which 10 per cent excess of benzathene was added. There was an inverse relationship between the concentration of bacterial lysate and the amount of benzathene needed for maximum precipitation. Thus 1.0 ml. of 40 OU/ml. of lysate required 3.25 mg benzathene, 1.0 ml. of 160 OU/ml. needed only 1.5 mg, 1.0 ml. of 320 OU/ml. needed 0.7 mg, and 1.0 ml. of 800 OU/ml. required 0.37 mg. After 2 h the precipitate was centrifuged off and resuspended in tris–chloride buffer. Table 1 shows the mouse protective activity2–4 of the benzathene precipitate and of the supernatant from the benzathene precipitation compared with a reference vaccine. It is clear that all detectable immunogen was in the insoluble fraction, which was found also to contain virtually all the histamine-sensitizing factor (HSF) and the pyrogen. Gravimetric estimations showed that the benzathene–pertussis precipitate represented 7 per cent of the dry weight of the original live cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barta, G., J. Immunol, 90, 73 (1963).
Wilson, E. B., and Worcester, J., Proc. U. S. Nat. Acad. Sci., 29, 208 (1943)
National Institutes of Health, Bethesda 14, Maryland, Memorandum, 1956.
National Institutes of Health, Minimum Requirements, Pertussis Vaccine, 1952.
Preston, N. W., J. Path. Bact., 78, 217 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BARTA, G. Precipitation of Pertussis Immunogen with Benzathene and Proflavine. Nature 206, 192–193 (1965). https://doi.org/10.1038/206192b0
Issue Date:
DOI: https://doi.org/10.1038/206192b0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.